Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: A study of the Acute Myeloid Leukemia Study Group Ulm

Journal of Clinical Oncology

Volumn 20, Issue 15, 2002, Pages 3254-3261

  Döhner, Konstanze ^a   Tobis, Karen ^a   Ulrich, Regina ^a   Fröhling, Stefan ^a   Benner, Axel ^a   Schlenk, Richard F ^a   Döhner, Hartmut ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; IDARUBICIN; MITOXANTRONE; MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; DOSE RESPONSE; FEMALE; GENE DUPLICATION; GENETIC LINKAGE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; SOUTHERN BLOTTING;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOTTING, SOUTHERN; CHROMOSOMES, HUMAN, PAIR 11; DNA-BINDING PROTEINS; FEMALE; GENE DUPLICATION; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELOID-LYMPHOID LEUKEMIA PROTEIN; POLYMERASE CHAIN REACTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTO-ONCOGENES; STATISTICS, NONPARAMETRIC; TRANSCRIPTION FACTORS;

EID: 0036682174     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.09.088     Document Type: Article

References (30)

1. Clinical importance of cytogenetics in acute myeloid leukaemia
2. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype
3. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial - The Medical Research Council Adult and Children's Leukemia Working Parties
4. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group study
5. Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocations
6. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 translocations
7. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene
8. Core-binding factor (CBF) and MLL-associated primary acute myeloid leukemia: Biology and clinical implications
9. Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11
10. The partial tandem duplication of ALL1 in acute myeloid leukemia with normal cytogenetics or trisomy 11 is restricted to one chromosome
11. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukemia
12. Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: Distinct origin of normal versus leukemic ALL1 fusion transcripts
13. Partial tandem duplication of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors
14. Rearrangement of the ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics
15. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavourable subset of AML
16. Stratification of postremission therapy in adult acute myeloid leukemia according to the karyotype: First results of the AML HD93 multicenter treatment trial
17. Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group
18. Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia
19. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia
20. ALL-1 partial duplication in acute leukemia
21. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias
22. Structure and expression of the human trithorax-like gene I involved in acute leukemias
23. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia
24. Censoring distributions as a measure of follow-up in survival analysis
25. Non-parametric estimation from incomplete observation
26. Statistical aspects of the analysis of data from retrospective studies of disease
27. Regression models and life tables
28. Less intense conditioning with fludarabine, cyclophosphamide, idarubicin and etoposide (FCIE) followed by allogeneic unselected peripheral blood stem cell transplantation in elderly patients with leukemia
29. Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: Results of a phase I-II study